No offence but that sounds delusional.
Demoralisation of shareholders is due to the actions of a company where they focus more on marketing themselves to keep up with the constant funding cycles rather than focusing on monetising their IP as efficiently as possible.
You raised a good question. Why do they have a marketing department? They don't have anything to sell. Are 10m a quarter in staff wages in line with a small R&D based device company? Wayne and management have experience in large pharma companies, but AVR isn't one. They need to learn to crawl before they can walk.
No offence but that sounds delusional. Demoralisation of...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 84 | $17.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.65 | 1228 | 3 |
View Market Depth
| Last trade - 12.47pm 23/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable